|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/20 Inhibitor Therapeutics, Inc. 10-K 12/31/19 43:3.3M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 705K
2: EX-23.1 Consent of Experts or Counsel HTML 15K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 21K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 16K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 16K
15: R1 Cover Page HTML 60K
28: R2 Condensed Balance Sheets HTML 75K
40: R3 Condensed Balance Sheets (Parenthetical) HTML 38K
22: R4 Condensed Statements of Operations HTML 41K
16: R5 Condensed Statements of Stockholders' Equity HTML 56K
(Deficit)
29: R6 Condensed Statements of Cash Flows HTML 59K
41: R7 Corporate overview HTML 83K
21: R8 Liquidity and management's plans HTML 31K
17: R9 Summary of Significant Accounting Policies HTML 31K
34: R10 Income Taxes HTML 49K
37: R11 Stockholders' Equity HTML 101K
27: R12 Related Party Transactions HTML 19K
14: R13 Legal Proceedings HTML 26K
33: R14 Summary of Significant Accounting Policies HTML 54K
(Policies)
35: R15 Income Taxes (Tables) HTML 48K
26: R16 Stockholders' Equity (Tables) HTML 100K
13: R17 Corporate Overview - Additional Information HTML 126K
(Detail)
32: R18 Liquidity and Management's Plans - Additional HTML 19K
Information (Detail)
39: R19 Summary of Significant Accounting Policies - HTML 48K
Additional Information (Detail)
24: R20 Income Taxes - The Difference Between Expected HTML 31K
Income Tax Benefits and Income Tax Benefit
Recorded in The Financial Statements (Detail)
19: R21 Income Taxes - Components of Deferred Income Tax HTML 38K
Assets and Liabilities (Detail)
31: R22 Income Taxes - Additional Information (Detail) HTML 33K
43: R23 Stockholders' Equity - Schedule of Stock Option HTML 42K
Activity (Detail)
23: R24 Stockholders' Equity - Information Regarding Stock HTML 59K
Options Outstanding and Exercisable (Detail)
18: R25 Stockholders' Equity - Summary of Non-vested Stock HTML 30K
Option Activity (Detail)
30: R26 Stockholders' Equity - Summary of Warrant HTML 24K
Exercises (Detail)
42: R27 Stockholders' Equity - Additional Information HTML 68K
(Detail)
25: R28 Related Party Transactions - Additional HTML 24K
Information (Detail)
20: XML IDEA XML File -- Filing Summary XML 67K
36: EXCEL IDEA Workbook of Financial Reports XLSX 42K
7: EX-101.INS XBRL Instance -- hppi-20191231 XML 759K
9: EX-101.CAL XBRL Calculations -- hppi-20191231_cal XML 68K
10: EX-101.DEF XBRL Definitions -- hppi-20191231_def XML 373K
11: EX-101.LAB XBRL Labels -- hppi-20191231_lab XML 669K
12: EX-101.PRE XBRL Presentations -- hppi-20191231_pre XML 497K
8: EX-101.SCH XBRL Schema -- hppi-20191231 XSD 94K
38: ZIP XBRL Zipped Folder -- 0001193125-20-090201-xbrl Zip 85K
| EX-32.2 |
Exhibit 32.2
CERTIFICATION
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(18 U.S.C. 1350)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350), the undersigned officer of Inhibitor Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to the best of such officer’s knowledge and belief, that:
(1) The Annual Report on Form 10-K for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Form 10-K fairly presents, in all materials respects, the financial condition and results of operations of the Company.
| Date: March 30, 2020 | ||||||
| Garrison J. Hasara, Chief Financial Officer and Treasurer |
This certification shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Securities Exchange Act.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/30/20 | |||
| For Period end: | 12/31/19 | 5, 8-K | ||
| List all Filings | ||||